Acute pancreatitis following COVID-19 vaccine: A case report and brief literature review

Boskabadi, Javad; Ala, Shahram; Heydari, Fatemeh; Ebrahimi, Milad; Nikzad, Alireza

doi:10.1016/j.heliyon.2023.e12914

Cited by 12 publications

(24 citation statements)

References 41 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[16][17][18][19][20][21][22] An isolated case of acute pancreatitis was thought to be related to inactivated Covid-19 vaccine (Sinopharm BIBP). 23 In the reported cases, patients were mostly female (N = 8) (SR 0.75). The remaining case of pancreatitis was an AIP type I, occurring 1 month after administration of the mRNA-platform Covid-19 vaccine for which the brand type was not reported in the study.…”

Section: Discussionmentioning

confidence: 87%

“…25 As shown in Table 1, pancreatitis occurred after the first dose of the Covid-19 vaccine in eight patients, 12,14,16,[18][19][20][21][22] and after the second dose in four cases. 15,17,23,25 Two cases of acute pancreatitis were identified after the third booster dose of the Pfizer/BioNTech Covid-19 mRNA vaccine. 13 Two patients agreed to have a second booster of the mRNA vaccine.…”

Section: Discussionmentioning

confidence: 99%

“…To the best of our knowledge, 14 cases of pancreatitis have been reported after vaccination against SARS‐CoV‐2 12–25 . Twelve case reports of acute pancreatitis occurred within a brief period (10 hours to 7 days) administration of the mRNA vaccine (Pfizer‐BioNTech) 16–22 .…”

Section: Discussionmentioning

confidence: 99%

“…To the best of our knowledge, 14 cases of pancreatitis have been reported after vaccination against SARS-CoV-2. [12][13][14][15][16][17][18][19][20][21][22][23][24][25] Twelve case reports of acute pancreatitis occurred within a brief period (10 hours to 7 days) administration of the mRNA vaccine (Pfizer-BioNTech). [16][17][18][19][20][21][22] An isolated case of acute pancreatitis was thought to be related to inactivated Covid-19 vaccine (Sinopharm BIBP).…”

Section: Discussionmentioning

confidence: 99%

“…Twelve case reports of acute pancreatitis occurred within a brief period (10 hours to 7 days) administration of the mRNA vaccine (Pfizer‐BioNTech) 16–22 . An isolated case of acute pancreatitis was thought to be related to inactivated Covid‐19 vaccine (Sinopharm BIBP) 23 . In the reported cases, patients were mostly female (N = 8) (SR 0.75).…”

Section: Discussionmentioning

confidence: 99%

See 4 more Smart Citations

An unusual occurrence of autoimmune pancreatitis after gam‐Covid‐Vac (Sputnik V): A case report and literature review

Fadhel

Maamri

Abdelali

et al. 2023

Brit J Clinical Pharma

View full text Add to dashboard Cite

The safety profile of the Sputnik V vaccine is generally reassuring. Nevertheless, an enhanced risk of new‐onset of immune‐mediated diseases has been increasingly reported following the adenoviral‐based Covid‐19 vaccine, including inflammatory arthritis, Guillain‐Barré syndrome, optical neuromyelitis, acute disseminated encephalomyelitis, subacute thyroiditis and acute liver injury as well as glomerulopathy. However, no case of autoimmune pancreatitis has been reported yet. Herein, we describe a case of type I autoimmune pancreatitis that may be due to the Sputnik V Covid‐19 vaccine.

show abstract

Section: Discussionmentioning

confidence: 87%

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

See 3 more Smart Citations

An unusual occurrence of autoimmune pancreatitis after gam‐Covid‐Vac (Sputnik V): A case report and literature review

Fadhel

Maamri

Abdelali

et al. 2023

Brit J Clinical Pharma

View full text Add to dashboard Cite

show abstract

Eliminating COVID‐19 as the immediate culprit for igniting pancreatitis

Ge,

Luo,

Liu

et al. 2023

Journal of Medical Virology

View full text Add to dashboard Cite

The impact of severe acute respiratory syndrome coronavirus 2 infection on the potential development of pancreatitis is a subject of ongoing debate within academic discourse. Establishing a causal link between COVID‐19 and pancreatitis may not be fully supported by relying only on retrospective studies or case reports. This study examined the relationship between COVID‐19 phenotypes and pancreatitis by Mendelian randomization (MR) method. The identification of instrumental variables (single nucleotide polymorphisms) that exhibit a robust association with the COVID‐19 phenotypes was accomplished through a meticulous process of rigorous screening procedures. We included acute pancreatitis and chronic pancreatitis (CP) as the outcomes in the MR analysis, even though no definitive studies exist between COVID‐19 and CP. A direct causal relationship between genetically predicted COVID‐19 phenotypes and pancreatitis risk cannot be established. There is an ongoing debate over the designation of COVID‐19 as a definitive cause of pancreatitis.

show abstract